Biovica receives patent approval in US

Biovica has recently received patent approval for the DiviTum™ technology by the United States patent office. The granting of this latest patent means that DiviTum™ now has patent protection in both the US & Canada and across Europe, in total 44 countries.   This patent concerns the technology to measure cell proliferation rate by analysing thymidine [...]

2014-08-15T11:00:57+00:00 August 15th, 2014 11:00|Regulatory|